文献速递垂体与肾上腺疾病

垂体柄增厚的病因谱与变化模式:321例经验

Etiological Spectrum and Pattern of Change in Pituitary Stalk Thickening: Experience in 321 Patients.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

2014年1月至2017年5月北京协和医院321例MRI确诊垂体柄增厚患者中,中央性尿崩症为首发症状者占68.8%,57.6%存在至少一种垂体前叶激素缺乏;137例(42.7%)确立病因,以肿瘤为主(75.2%)。

要点

  • 中央性尿崩症是垂体柄增厚最常见首发表现,占68.8%。
  • 下丘脑受累与全垂体功能减退相关,校正OR为7.3。
  • 儿童以颅内生殖细胞肿瘤为主,成人以组织细胞增生症和恶性转移多见。

核心结论

  • 垂体柄增厚病因高度异质,多数确诊病例为肿瘤,病因谱随年龄变化。

研究设计与样本

  • 回顾性收集2014年1月至2017年5月北京协和医院321例MRI确诊垂体柄增厚患者的临床、实验室、影像、手术、病理及随访资料。

主要发现

  • 321例中28.3%年龄≤18岁,中央性尿崩症为首发症状者占68.8%,57.6%存在至少一种垂体前叶激素缺乏。
  • 下丘脑受累与全垂体功能减退相关,校正OR为7.3(95%CI 3.0至17.8,P<0.001)。
  • 137例(42.7%)确立病因,其中肿瘤占75.2%、炎症占13.1%、先天异常占11.7%。
  • 儿童以颅内生殖细胞肿瘤为主(66.7%),成人以组织细胞增生症(20.0%)和恶性转移(14.7%)最常见。

临床怎么用

  • 应熟悉垂体柄增厚的主要鉴别诊断、必要检查及随访策略。
  • 影像学进展和/或垂体功能恶化时建议活检。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To summarize the etiologies of pituitary stalk thickening (PST) and the natural course of indistinguishable PST. METHODS: Clinical information, including the symptoms at onset and laboratory, imaging, operative, pathological, and follow-up data, of patients with MRI-confirmed PST at Peking Union Medical College Hospital from January 2014 to May 2017 was collected and reviewed. RESULTS: Of 321 eligible patients with PST, 28.3% were ≤18 years old. Central diabetes insipidus was the initial symptom in 68.8% of patients. At least one anterior pituitary hormone deficit was found in 57.6% of patients. The adjusted OR of panhypopituitarism associated with hypothalamus involvement was 7.3 (95% CI, 3.0 to 17.8; P < 0.001). Confirmed diagnoses were established in 137 patients (42.7%), including neoplasms (75.2%), inflammation (13.1%), and congenital anomalies (11.7%). Intracranial germ cell tumors (66.7%) were the leading cause among children, whereas histiocytoses (20.0%) and malignant metastases (14.7%) were the most common causes in adults. Thirty-eight patients with indistinguishable PST underwent a second MRI at a median time of 4.4 months. Spontaneous remission was observed in 17 of these patients (44.7%) after a median 8.5 months, with complete remission in 14 (36.8%) and partial remission in three (7.0%); five (13.2%) patients exhibited progression, and the remaining 16 (42.1%) stabilized. CONCLUSION: PST is highly heterogeneous, and most confirmed cases are attributed to neoplasms. The etiological spectrum varies with age. Physicians must be familiar with the major differential diagnoses, necessary investigations, and follow-up. Biopsy is indicated when radiological progression and/or worsening of pituitary function is detected.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhou X, Zhu H, Yao Y, et al. Etiological Spectrum and Pattern of Change in Pituitary Stalk Thickening: Experience in 321 Patients. J Clin Endocrinol Metab. 2019. PMID: 30892632. doi:10.1210/jc.2018-02297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。